MC1440A1 - Derives de la pyrrolidine,sa preparation et ses utilisations therapeutiques pour le traitement de l'insuffisance cerebrale - Google Patents
Derives de la pyrrolidine,sa preparation et ses utilisations therapeutiques pour le traitement de l'insuffisance cerebraleInfo
- Publication number
- MC1440A1 MC1440A1 MC821572A MC1572A MC1440A1 MC 1440 A1 MC1440 A1 MC 1440A1 MC 821572 A MC821572 A MC 821572A MC 1572 A MC1572 A MC 1572A MC 1440 A1 MC1440 A1 MC 1440A1
- Authority
- MC
- Monaco
- Prior art keywords
- preparation
- treatment
- therapeutic uses
- pyrrolidine derivatives
- cerebral deficiency
- Prior art date
Links
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical class C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 title 1
- 230000002490 cerebral effect Effects 0.000 title 1
- 230000007812 deficiency Effects 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
- C07D207/273—2-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/10—Compounds having one or more C—Si linkages containing nitrogen having a Si-N linkage
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Psychiatry (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hospice & Palliative Care (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pyrrole Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH77081A CH646149A5 (de) | 1981-02-05 | 1981-02-05 | Pyrrolidin-derivat. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MC1440A1 true MC1440A1 (fr) | 1982-12-06 |
Family
ID=4194769
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MC821572A MC1440A1 (fr) | 1981-02-05 | 1982-02-03 | Derives de la pyrrolidine,sa preparation et ses utilisations therapeutiques pour le traitement de l'insuffisance cerebrale |
Country Status (40)
| Country | Link |
|---|---|
| US (1) | US4452807A (es) |
| EP (1) | EP0057846B1 (es) |
| JP (1) | JPS57146753A (es) |
| KR (1) | KR830009023A (es) |
| AR (1) | AR231127A1 (es) |
| AT (2) | ATE13668T1 (es) |
| AU (1) | AU552063B2 (es) |
| BG (1) | BG36932A3 (es) |
| BR (1) | BR8200615A (es) |
| CA (1) | CA1158250A (es) |
| CH (1) | CH646149A5 (es) |
| CS (1) | CS227035B2 (es) |
| DD (1) | DD202539A5 (es) |
| DE (2) | DE3263960D1 (es) |
| DK (1) | DK20682A (es) |
| ES (1) | ES509312A0 (es) |
| FI (1) | FI820192L (es) |
| FR (1) | FR2499075A1 (es) |
| GB (1) | GB2092584B (es) |
| GR (1) | GR76052B (es) |
| HU (1) | HU184988B (es) |
| IE (1) | IE52439B1 (es) |
| IL (1) | IL64896A (es) |
| IS (1) | IS2700A7 (es) |
| IT (1) | IT1153402B (es) |
| LU (1) | LU83923A1 (es) |
| MC (1) | MC1440A1 (es) |
| NL (1) | NL8200337A (es) |
| NO (1) | NO820346L (es) |
| NZ (1) | NZ199624A (es) |
| OA (1) | OA07002A (es) |
| PH (1) | PH18267A (es) |
| PL (1) | PL135221B1 (es) |
| PT (1) | PT74387B (es) |
| RO (1) | RO83099B (es) |
| SE (1) | SE8200647L (es) |
| SU (1) | SU1143315A3 (es) |
| YU (1) | YU23982A (es) |
| ZA (1) | ZA82608B (es) |
| ZW (1) | ZW1982A1 (es) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2515179A1 (fr) * | 1981-07-24 | 1983-04-29 | Hoffmann La Roche | Derives de pyrrolidine, leur procede de preparation, les intermediaires pour leur synthese et leur application therapeutique |
| FR2551751B1 (fr) * | 1983-09-12 | 1986-04-25 | Serobiologiques Lab Sa | Nouveau procede de preparation d'un derive pyroglutamique, nouveaux derives pyroglutamiques, nouveaux intermediaires de synthese de preparation de ceux-ci et utilisation ou application des derives pyroglutamiques comme agents antibacteriens ou antifongiques |
| DE3336024A1 (de) * | 1983-10-04 | 1985-04-18 | Boehringer Ingelheim KG, 6507 Ingelheim | 4-amino-l-benzyl-pyrrolidinone und ihre saeureadditionssalze, verfahren zu ihrer herstellung und arzneimittel |
| DE3537075A1 (de) * | 1985-10-18 | 1987-04-23 | Bayer Ag | Verfahren zur herstellung von clausenamid |
| DE3632589A1 (de) * | 1985-10-18 | 1987-04-23 | Bayer Ag | Verfahren zur herstellung von (gamma)-butyrolactamen |
| US4677114A (en) * | 1985-11-22 | 1987-06-30 | Warner-Lambert Company | Pyrrolidone-2 derivatives and pharmaceutical compositions thereof |
| IT1215587B (it) * | 1987-06-26 | 1990-02-14 | Roussel Maestretti Spa | Derivati della 1-benzoil2-oxo 5-alcossi pirrolidina, loro procedimento di preparazione e loro impiego come sostanza medicinale. |
| JPH0720930B2 (ja) * | 1988-07-09 | 1995-03-08 | 明治製菓株式会社 | ピロリジノン化合物及び脳機能障害改善剤 |
| US5049577A (en) * | 1990-01-29 | 1991-09-17 | E. R. Squibb & Sons, Inc. | 2-pyrrolidone substituted dihydroxy alkanoic, alkenoic and alkynoic acids, compositions and HMG-CoA reductase inhibition therewith |
| US5049578A (en) * | 1990-03-09 | 1991-09-17 | E. R. Squibb & Sons, Inc. | 1-aroyl or 1-acyl-2-2pyrrolidinyl-3,5-dihydroxy alkanoic and alkenoic acids, salts, esters and lactones |
| ATE215079T1 (de) * | 1992-07-24 | 2002-04-15 | Univ California | Arzneimittel, die den durch ampa rezeptoren vermittelten synaptischen respons erhöhen |
| US5852008A (en) * | 1995-01-24 | 1998-12-22 | The Regents Of The University Of California | Heteroatom substituted benzoyl derivatives that enhance synaptic response mediated by receptors |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES433723A1 (es) * | 1975-01-10 | 1976-11-16 | Lafarquim S A Lab | Procedimiento de obtencion de un derivado de 2-pirrolidi- nona. |
| IT1045043B (it) * | 1975-08-13 | 1980-04-21 | Isf Spa | Derivati pirrolidinici |
| CU21107A3 (es) * | 1978-02-10 | 1988-02-01 | Hoffmann La Roche | Pyrrolidines derivatives |
| CA1115212A (en) * | 1978-02-10 | 1981-12-29 | Emilio Kyburz | Pyrrolidine derivatives |
| IT1131959B (it) * | 1979-08-09 | 1986-06-25 | Hoffmann La Roche | Derivati pirrolidinici |
-
1981
- 1981-02-05 CH CH77081A patent/CH646149A5/de not_active IP Right Cessation
-
1982
- 1982-01-08 CA CA000393829A patent/CA1158250A/en not_active Expired
- 1982-01-14 IT IT19115/82A patent/IT1153402B/it active
- 1982-01-18 DK DK20682A patent/DK20682A/da not_active Application Discontinuation
- 1982-01-20 US US06/340,920 patent/US4452807A/en not_active Expired - Fee Related
- 1982-01-21 FI FI820192A patent/FI820192L/fi not_active Application Discontinuation
- 1982-01-25 DE DE8282100494T patent/DE3263960D1/de not_active Expired
- 1982-01-25 AT AT82100494T patent/ATE13668T1/de not_active IP Right Cessation
- 1982-01-25 DE DE19823202281 patent/DE3202281A1/de not_active Withdrawn
- 1982-01-25 EP EP82100494A patent/EP0057846B1/de not_active Expired
- 1982-01-28 OA OA57598A patent/OA07002A/xx unknown
- 1982-01-29 PH PH26797A patent/PH18267A/en unknown
- 1982-01-29 NL NL8200337A patent/NL8200337A/nl not_active Application Discontinuation
- 1982-01-29 ZW ZW19/82A patent/ZW1982A1/xx unknown
- 1982-01-29 IL IL64896A patent/IL64896A/xx unknown
- 1982-01-29 ZA ZA82608A patent/ZA82608B/xx unknown
- 1982-01-29 CS CS82629A patent/CS227035B2/cs unknown
- 1982-01-30 RO RO106487A patent/RO83099B/ro unknown
- 1982-02-01 NZ NZ199624A patent/NZ199624A/en unknown
- 1982-02-01 HU HU82285A patent/HU184988B/hu unknown
- 1982-02-02 JP JP57014411A patent/JPS57146753A/ja active Granted
- 1982-02-02 AU AU80104/82A patent/AU552063B2/en not_active Ceased
- 1982-02-02 AR AR288323A patent/AR231127A1/es active
- 1982-02-03 GR GR67187A patent/GR76052B/el unknown
- 1982-02-03 DD DD82237159A patent/DD202539A5/de not_active IP Right Cessation
- 1982-02-03 MC MC821572A patent/MC1440A1/xx unknown
- 1982-02-03 SU SU823381951A patent/SU1143315A3/ru active
- 1982-02-03 FR FR8201714A patent/FR2499075A1/fr not_active Withdrawn
- 1982-02-04 ES ES509312A patent/ES509312A0/es active Granted
- 1982-02-04 YU YU00239/82A patent/YU23982A/xx unknown
- 1982-02-04 LU LU83923A patent/LU83923A1/de unknown
- 1982-02-04 AT AT0041882A patent/AT377982B/de not_active IP Right Cessation
- 1982-02-04 BR BR8200615A patent/BR8200615A/pt unknown
- 1982-02-04 IS IS2700A patent/IS2700A7/is unknown
- 1982-02-04 KR KR1019820000475A patent/KR830009023A/ko unknown
- 1982-02-04 GB GB8203264A patent/GB2092584B/en not_active Expired
- 1982-02-04 NO NO820346A patent/NO820346L/no unknown
- 1982-02-04 IE IE249/82A patent/IE52439B1/en unknown
- 1982-02-04 SE SE8200647A patent/SE8200647L/xx not_active Application Discontinuation
- 1982-02-04 PT PT74387A patent/PT74387B/pt unknown
- 1982-02-05 BG BG8255269A patent/BG36932A3/xx unknown
- 1982-02-05 PL PL1982234962A patent/PL135221B1/pl unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BE889930A (fr) | Derives de l'indole, leur preparation et leurs utilisations therapeutiques | |
| OA08617A (fr) | Inhibiteurs de métalloendopeptidase neutre dans le traitement de l'hypertention. | |
| BE890024A (fr) | Derives tricycliques de l'imidazole, leur preparation et leurs utilisations therapeutiques | |
| BE896027A (fr) | Nouvelles glycoproteines, procedes de production et agents therapeutiques pour le traitement de tumeurs en contenant | |
| BE889929A (fr) | Derives de l'indole, leur preparation et leurs utilisations therapeutiques | |
| MC1440A1 (fr) | Derives de la pyrrolidine,sa preparation et ses utilisations therapeutiques pour le traitement de l'insuffisance cerebrale | |
| FR2556348B1 (fr) | Retinoides, leur preparation et leurs utilisations therapeutiques, notamment pour le traitement des neoplasies, de l'acne et du psoriasis | |
| MC1998A1 (fr) | Composes pour le traitement des maladies hyperproliferatibes et procede de preparation | |
| FR2554814B1 (fr) | Oxazolidines, procede pour leur preparation et leurs utilisations therapeutiques, notamment dans le traitement de l'obesite et du diabete | |
| FR2636985B1 (fr) | Composition assouplissante et procede pour le traitement de textiles | |
| FR2585018B1 (fr) | Poly-4-aminopyrrole-2-carboxamides et derives, procede pour leur preparation et leurs utilisations therapeutiques | |
| FR2556956B3 (fr) | Prothese penienne semi-rigide pour le traitement des impuissances d'erection | |
| FR2612775B1 (fr) | Compositions pour la prevention et le traitement de la degenerescence cutanee | |
| FR2666334B1 (fr) | Procede continu de preparation d'acrylamides et de methacrylamides n-substitues. | |
| FR2558372B1 (fr) | Composition medicamenteuse pour le traitement de l'acne | |
| FR2310769A1 (fr) | Medicament pour le traitement de l'alopecia seborrhoeica | |
| FR2658419B1 (fr) | Medicament pour le traitement de la dermatite. | |
| BE860992A (fr) | Composition et tampon pour le traitement ou la prevention de l'acne et d'affections de la peau similaires | |
| MA19564A1 (fr) | Derives de la pyrrolidine, sa preparation et ses utilisations therapeutiques pour le traitement de l'insuffisance cerebrale | |
| FR2510991B1 (fr) | Procede pour la preparation de methacrylamides et d'acrylamides n-substitues | |
| FR2544614B1 (fr) | Nouvelle association medicamenteuse pour le traitement de l'hypertension | |
| BE892602A (fr) | Esters de mercaptoacyl-carnitines, procede pour leur preparation et leurs utilisations therapeutiques | |
| FR2503150B1 (fr) | Mercaptoacyl-carnitines, procede pour leur preparation et leurs utilisations therapeutiques dans le traitement des intoxications et des brulures et en tant qu'agents mucolytiques | |
| RO79428A2 (ro) | Compozitie medicamentoasa destinata tratamentului dermatozelor | |
| RO87007A (ro) | Procedeu si instalatie pentru prepararea izomerozei |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| YP | Annual fee paid |